Iqvia Holdings Inc. | Large-cap | Healthcare
$164.65
1.25%
| Iqvia Holdings Stock Comparison:
Iqvia Holdings vs Thermo FisherIqvia Holdings vs DanaherIqvia Holdings vs Idexx LaboratoriesIqvia Holdings vs Agilent TechnologiesIqvia Holdings vs Mettler-ToledoIqvia Holdings vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 15.4B
Gross Profit 5.4B 34.89%
Operating Income 2.3B 14.73%
Net Income 1.4B 8.91%
EPS (Diluted) $7.49

Balance Sheet Metrics

Total Assets 26.9B
Total Liabilities 20.8B
Shareholders Equity 6.1B
Debt to Equity 3.43

Cash Flow Metrics

Operating Cash Flow 2.9B
Free Cash Flow 2.1B

Revenue & Profitability Trend

Iqvia Holdings Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 15.4B 15.0B 14.4B 13.9B 11.4B
Cost of Goods Sold 10.0B 9.7B 9.4B 9.2B 7.5B
Gross Profit 5.4B 5.2B 5.0B 4.6B 3.9B
Operating Expenses 2.0B 2.1B 2.1B 2.0B 1.8B
Operating Income 2.3B 2.1B 1.8B 1.4B 783.0M
Pre-tax Income 1.7B 1.5B 1.4B 1.1B 373.0M
Income Tax 301.0M 101.0M 260.0M 163.0M 72.0M
Net Income 1.4B 1.4B 1.1B 971.0M 308.0M
EPS (Diluted) $7.49 $7.29 $5.72 $4.95 $1.43

Income Statement Trend

Iqvia Holdings Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 5.8B 5.6B 5.0B 4.8B 5.1B
Non-Current Assets 21.1B 21.1B 20.4B 19.9B 19.5B
Total Assets 26.9B 26.7B 25.3B 24.7B 24.6B
Liabilities
Current Liabilities 7.0B 6.5B 5.6B 5.2B 4.6B
Non-Current Liabilities 13.9B 14.1B 14.0B 13.4B 13.7B
Total Liabilities 20.8B 20.6B 19.6B 18.6B 18.3B
Equity
Total Shareholders Equity 6.1B 6.1B 5.8B 6.0B 6.3B

Balance Sheet Composition

Iqvia Holdings Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income 1.4B 1.4B 1.1B 971.0M 308.0M
Operating Cash Flow 2.9B 2.3B 2.4B 3.0B 2.2B
Investing Activities
Capital Expenditures -577.0M -649.0M -674.0M -640.0M -616.0M
Investing Cash Flow -1.4B -1.6B -2.0B -2.1B -796.0M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow -814.0M -3.0B -2.3B -1.8B -1.8B
Free Cash Flow 2.1B 1.5B 1.6B 2.3B 1.3B

Cash Flow Trend

Iqvia Holdings Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 21.64
Forward P/E 13.12
Price to Book 4.61
Price to Sales 1.77
PEG Ratio 13.12

Profitability Ratios

Profit Margin 8.61%
Operating Margin 13.71%
Return on Equity 21.64%
Return on Assets 5.30%

Financial Health

Current Ratio 0.82
Debt to Equity 242.91
Beta 1.29

Per Share Data

EPS (TTM) $7.32
Book Value per Share $34.33
Revenue per Share $86.21

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
iqv 27.4B 21.64 4.61 21.64% 8.61% 242.91
Thermo Fisher 152.5B 23.69 3.09 13.70% 15.19% 69.23
Danaher 140.5B 37.98 2.76 7.22% 15.81% 34.56
Idexx Laboratories 42.1B 48.33 29.21 59.33% 22.76% 73.16
Agilent Technologies 33.0B 28.60 5.37 18.88% 17.59% 60.04
Mettler-Toledo 24.0B 28.82 -135.91 -680.23% 22.17% -11.40

Financial data is updated regularly. All figures are in the company's reporting currency.